Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Quality Alerts: US FDA Issues Form 483 to Dr. Reddy's Laboratories Unit 6 - Dr. Reddy\'s Laboratories

Dr. Reddy's Laboratories

Uploaded: 2018

Enforcement Report - Week of November 6, 2024

06 Nov 2024

// FDA

Dr. Reddy’s Q2 & H1FY25 Financial Results

05 Nov 2024

// BUSINESSWIRE

Dr. Reddys`s Generics Dasatinib Receives Tentative Approval in US

04 Nov 2024

// FDA

DATA COMPILATION
#PharmaFlow

DRL

Contact Supplier

CPhI India 2024

Booth #RH.E02

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, API Product List 2024, Products Under Development 2024, FDF Product List 2024, GMP Certificate 2024

Product List 2024
Corporate Presentation
API Product List 2024
Products Under Development 2024
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

1 VLOG #PharmaReel, 8 CORPORATE CONTENT #SupplierSpotlight, 4 DATA COMPILATION #PharmaFlow, 1070 NEWS #PharmaBuzz

1 VLOG #PharmaReel
8 CORPORATE CONTENT #SupplierSpotlight
4 DATA COMPILATION #PharmaFlow
1070 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

235 All APIs, 156 USDMF, 51 CEP/COS, 30 JDMF, 136 EU WC, 148 KDMF, 187 NDC API, 146 Listed APIs

235 All APIs
156 USDMF
51 CEP/COS
30 JDMF
136 EU WC
148 KDMF
187 NDC API
146 Listed APIs

DEVELOPMENTS

136 Drugs in Development

136 Drugs in Development

FINISHED DOSAGE FORMULATIONS

803 FDF Dossiers, 570 FDA Orange Book, 10 Europe, 223 Listed Dossiers

803 FDF Dossiers
570 FDA Orange Book
10 Europe
223 Listed Dossiers

KEY PRODUCTS

Capecitabine, Carfilzomib, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Enzalutamide, Eribulin, Ferric Carboxymaltose, Iron Sucrose, Mirabegron, Nilotinib, Olaparib, Palbociclib, Quetiapine Hemifumarate, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sugammadex Sodium

Capecitabine
Carfilzomib
Dabigatran Etexilate Mesylate
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Enzalutamide
Eribulin
Ferric Carboxymaltose
Iron Sucrose
Mirabegron
Nilotinib
Olaparib
Palbociclib
Quetiapine Hemifumarate
Rivaroxaban
Sacubitril-Valsartan
Sitagliptin Hydrochloride
Sitagliptin Malate
Sitagliptin Phosphate
Sugammadex Sodium

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

67 FDA, 35 EDQM, 18 GDUFA

67 FDA
35 EDQM
18 GDUFA

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?